Nanalysis Scientific (TSXV:NSCI) Total Current Assets : C$18.99 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Nanalysis Scientific's total current assets for the quarter that ended in Mar. 2024 was C$18.99 Mil.

Nanalysis Scientific Total Current Assets Historical Data

The historical data trend for Nanalysis Scientific's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Total Current Assets Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

10.17

9.35

20.76

21.96

17.91

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															19.24	22.28	16.38	17.91	18.99

Nanalysis Scientific Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Nanalysis Scientific's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.759	+	9.758	+	5.794	+	1.603
	=	17.91

Nanalysis Scientific's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.694	+	10.667	+	4.827	+	1.804
	=	18.99

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Nanalysis Scientific (TSXV:NSCI) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Nanalysis Scientific's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.694	-	28.206	+	0.75 * 9.241	+	0.5 * 4.827
=	-17.17

Nanalysis Scientific Total Current Assets Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines